2019
DOI: 10.3390/ijms20030681
|View full text |Cite
|
Sign up to set email alerts
|

Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease

Abstract: Development of the kidney can be altered in response to adverse environments leading to renal programming and increased vulnerability to the development of hypertension and kidney disease in adulthood. By contrast, reprogramming is a strategy shifting therapeutic intervention from adulthood to early life to reverse the programming processes. Nitric oxide (NO) is a key mediator of renal physiology and blood pressure regulation. NO deficiency is a common mechanism underlying renal programming, while early-life N… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
87
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 83 publications
(89 citation statements)
references
References 105 publications
(192 reference statements)
1
87
0
1
Order By: Relevance
“…Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, can be metabolized by dimethylarginine dimethylaminohydrolase to generate DMA and citrulline [38]. Noteworthily, DMA can come from the TMA−TMAO pathway as well the ADMA−NO pathway, and TMAO and ADMA both are uremic toxins related to cardiovascular risk [34,39]. Whether DMA links two pathways together to play a role in the development of hypertension in CKD awaits further elucidation.…”
Section: Discussionmentioning
confidence: 99%
“…Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of NO synthase, can be metabolized by dimethylarginine dimethylaminohydrolase to generate DMA and citrulline [38]. Noteworthily, DMA can come from the TMA−TMAO pathway as well the ADMA−NO pathway, and TMAO and ADMA both are uremic toxins related to cardiovascular risk [34,39]. Whether DMA links two pathways together to play a role in the development of hypertension in CKD awaits further elucidation.…”
Section: Discussionmentioning
confidence: 99%
“…It is a major risk factor for kidney disease and it is the result of kidney disease [15]. Development of the kidney can be altered in response to adverse environments leading to renal programming and increased vulnerability to the development of hypertension and kidney disease in adulthood [15]. NO is a key mediator of renal physiology and blood pressure regulation.…”
Section: The Renal Systemmentioning
confidence: 99%
“…NO is a key mediator of renal physiology and blood pressure regulation. NO deficiency is a common mechanism underlying renal programming [15]. Furthermore, the kidney is an organ rich with acetylated lysines, which are found in up to >2000 unique histone and nonhistone proteins, therefore being a target of epigenetic programming [59,60].…”
Section: The Renal Systemmentioning
confidence: 99%
See 2 more Smart Citations